Discover Zealand Pharma's innovative patent for GLP-1/GLP-2 dual agonist composi...
Discover how AstraZeneca's new patent revolutionizes AAV vector production with ...
The US company is part of a burgeoning artificial intelligence (AI) market in ea...
TERN-701 is a BCR-ABL tyrosine-kinase inhibitor being studied in a Phase I study...
Enhance gene expression and reduce immune responses with Selecta Biosciences' pa...
In an exclusive interview, Jaguar Health’s CEO discussed plans for the investiga...
Johnson & Johnson’s Tremfya is approved for plaque psoriasis and active psoriati...
Currently approved to treat hallucinations associated with Parkinson’s disease p...
Messages leaked by a think tank inflate cancer risk of gender-affirming hormone ...
The FDA approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tou...
Regulators, clinicians, and health care algorithm developers need to take additi...
A new online marketplace called aRukon is set to launch globally this year to he...
UnitedHealth Group quietly acquired dozens of outpatient facilities in 2023, acc...
Across the country, there’s widespread disagreement — among doctors, lawmakers, ...
While the NIH has been working toward inclusion of underrepresented groups in th...
